Paper Details

Paper Title

BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.

Paper Journal Title

Nature

Paper Citation Count

Paper Publication Year

2019

Bio Mention

-, ALK, ALK-mutated, MYCN-amplified neuroblastoma10 cells, BORIS, BORIS-, CCCTC-binding factor, CTCF, CTCFL, MYCN, brother of the regulator of imprinted sites, cancer, cancer cells, cancers7, chromatin, genes, genome, loci, neuroblastoma10, oncogenes, regulatory elements1, resistant cancer cells, structural domains, super-enhancers, treatment, treatment-resistant cancer cells

Mesh Descriptor

Author Name	Affiliation
Ruben Dries	Dana-Farber Cancer Institute
Ruben Dries	Dana-Farber Cancer Institute
Ruben Dries	Harvard Medical School
Ruben Dries	Dana-Farber Cancer Institute
Ruben Dries	Harvard Medical School
Ruben Dries	Dana-Farber Cancer Institute
Daniel S Day	Whitehead Institute for Biomedical Research
Daniel S Day
Nathanael S Gray	Dana-Farber Cancer Institute
Nathanael S Gray	Harvard Medical School
Nathanael S Gray	Dana-Farber Cancer Institute
Nathanael S Gray	Harvard Medical School
Stuart H Orkin	Dana-Farber Cancer Institute
Stuart H Orkin	Boston Children's Hospital
Stuart H Orkin	Harvard Stem Cell Institute, Harvard Medical School
Stuart H Orkin	Howard Hughes Medical Institute
Guo-Cheng Yuan	Dana-Farber Cancer Institute
Guo-Cheng Yuan	Harvard TC Chan School of Public Health

1 - 18

Paper Details

Column Actions

Datasets